Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients
MAPS
1 other identifier
observational
585
1 country
20
Brief Summary
To determine the associations among biometric data, arrhythmias, subject-reported symptoms and subject wellness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Shorter than P25 for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2020
CompletedFirst Submitted
Initial submission to the registry
February 9, 2021
CompletedFirst Posted
Study publicly available on registry
February 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2021
CompletedFebruary 9, 2022
February 1, 2022
1 year
February 9, 2021
February 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Biometric Data Associations to Arrhythmias
MCT Data Sets
30 days
Biometric Data Associations to Subject-Reported Symptoms
MCT Data Sets
30 days
Biometric Data Associations to Subject Wellness
MCT Data Sets
30 days
Secondary Outcomes (3)
Clinician Use of Biometric Data Associations to Arrhythmias
30 days
Clinician Use of Biometric Data Associations to Subject-Reported Symptoms
30 days
Clinician Use of Biometric Data Associations to Wellness Status of Subject
30 days
Study Arms (1)
Patients indicated for Mobile Cardiac Telemetry Monitoring
Patients indicated for Mobile Cardiac Telemetry Monitoring while meeting inclusion/exclusion criteria and enrolled in sequential manner.
Interventions
AMS records rhythm, heart rate, subject-reported symptoms, and multiple parameters that include respiration rate, activity and body posture.
Eligibility Criteria
Adult subjects, 21 years or older who: 1. Require mobile cardiac telemetry monitoring for the detection of non-lethal cardiac arrhythmias 2. Are without any cardiac implantable electronic devices, including loop recorders 3. Are without wearable cardioverter defibrillator 4. Are without Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time 5. Are not currently hospitalized 6. Do not have any skin condition that would prevent them from wearing the AMS device 7. Are not non-ambulatory 8. Are not reporting to be pregnant 9. Are not participating in another clinical study
You may qualify if:
- Subjects who require monitoring for non-lethal cardiac arrhythmias
- Subjects who have an indication for mobile cardiac telemetry (MCT) monitoring
- Subjects 21 years of age or older
You may not qualify if:
- Subjects with an implantable cardiac device such as left ventricular assistive device, pacemaker, implanted cardioverter defibrillator (ICD), cardiac resynchronization therapy device, subcutaneous ICD's, pressure monitors and loop monitors
- Subjects with wearable cardioverter defibrillator, Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time
- Subjects currently hospitalized
- Subjects with a skin condition preventing them from wearing the AMS device
- Subjects who are non-ambulatory
- Subjects who are self-reporting to be pregnant
- Subjects participating in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
Comprehensive Cardiovascular Medical Group
Bakersfield, California, 93309, United States
Cardiovascular Innovation and Research Center
Long Beach, California, 90813, United States
Heartbeat Cardiovascular Medical Group
Los Angeles, California, 90027, United States
Interventional Cardiology Group
West Hills, California, 91307, United States
Flagler Hospital/Flagler Health
Jacksonville, Florida, 32086, United States
Cardiovascular Institute of Central Florida
Ocala, Florida, 34476, United States
First Coast Heart and Vascular Center
Saint Augustine, Florida, 32086, United States
Cardiovascular Research of Northwest Indiana
Munster, Indiana, 46321, United States
Cardiovascular Research of Northwest
Munster, Indiana, 46321, United States
Jackson Heart Clinic
Jackson, Mississippi, 39216, United States
Trinity Medical
Cheektowaga, New York, 14227, United States
PMG Research of Wilmington
Wilmington, North Carolina, 28401, United States
Erlanger Health System
Chattanooga, Tennessee, 37403, United States
ClinicalTex Research LLC d/b/a PharmaTex Research
Amarillo, Texas, 79109, United States
Texas Cardiology Associates of Houston
Kingwood, Texas, 77339, United States
Heart Rhythm Specialists
McKinney, Texas, 75070, United States
CardioVoyage
McKinney, Texas, 75071, United States
Orion Medical Research
Pasadena, Texas, 77505, United States
Daniel W. Gottlieb, MD, PS
Burien, Washington, 98166, United States
St. Mary's Medical Center
Huntington, West Virginia, 25702, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ramu Perumal, PhD
Zoll Services LLC
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2021
First Posted
February 15, 2021
Study Start
December 15, 2020
Primary Completion
December 15, 2021
Study Completion
December 15, 2021
Last Updated
February 9, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share